drugset / Trial / NCT07587047

Adia Med of Winter Park LLC Lower Back Pain Research Study

NCT07587047 ↗

Phase 1 Recruiting 100 enrolled Adia Med of Winter Park LLC
RandomizedCrossoverSingle-blindTreatment

Summary

The goal of this clinical study is to evaluate the safety and preliminary efficacy of an investigational umbilical cord blood-derived stem cell and exosome infusion in adults with chronic lower back pain associated with degenerative spine disease. The primary questions this study aims to answer are whether the investigational infusion is safe and well tolerated and whether treatment may reduce pain and improve physical function and quality of life. Researchers will compare the investigational infusion to a placebo (saline solution) to evaluate potential treatment effects in participants with chronic mechanical lower back pain. Participants will receive either the investigational infusion or placebo intravenously during a study visit, complete pain, disability, and quality-of-life assessments, undergo magnetic resonance imaging (MRI) and laboratory testing, and attend follow-up evaluations over a 6-month period. Participants initially assigned to placebo may later receive the investigational treatment during an open-label crossover phase of the study.

Timeline

Start
2026-06-16
Primary completion
2028-01
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical Cord Blood-Derived Stem Cells and Exosomes Cell therapy — Intravenous

Indications